Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$82.16 - $96.94 $12,324 - $14,541
-150 Reduced 5.45%
2,600 $220,000
Q2 2022

Aug 12, 2022

SELL
$71.48 - $86.85 $167,978 - $204,097
-2,350 Reduced 46.08%
2,750 $228,000
Q1 2022

May 16, 2022

SELL
$74.28 - $92.69 $14,856 - $18,538
-200 Reduced 3.77%
5,100 $393,000
Q4 2021

Feb 15, 2022

BUY
$71.72 - $91.47 $19,364 - $24,696
270 Added 5.37%
5,300 $468,000
Q3 2021

Nov 15, 2021

BUY
$74.77 - $85.47 $85,985 - $98,290
1,150 Added 29.64%
5,030 $388,000
Q2 2021

Aug 16, 2021

BUY
$75.51 - $84.79 $45,306 - $50,874
600 Added 18.29%
3,880 $324,000
Q1 2021

May 14, 2021

BUY
$74.73 - $90.69 $245,114 - $297,463
3,280 New
3,280 $247,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Peapack Gladstone Financial Corp Portfolio

Follow Peapack Gladstone Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.